Find trials
Search tips

Pro-active Genetic Testing in Kidney Transplant Patients

Overview

About this study

The purpose of this study is to determine the prevalence of genetic mutations of cancer in kidney transplant patients receiving care at Mayo Clinic Arizona.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years.
  • Post transplant Kidney and Kidney Pancreas recipients.

Exclusion Criteria:

  • Simultaneous Liver Kidney Transplant.
  • Simultaneous Heart Kidney Transplant.
  • Non renal transplant history.

Eligibility last updated 12/15/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Girish Mour, M.B.B.S.

Closed for enrollment

Contact information:

Girish Mour M.B.B.S.

Mour.Girish@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Girish Mour, M.B.B.S.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Girish Mour M.B.B.S.

Mour.Girish@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20530344

Mayo Clinic Footer